(Q74307405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Anti-GM1 ganglioside antibodies in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Antonio Gambardella

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M Zappia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Crescibene

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Bosco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Arabia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Bagalà

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Bastone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I D Napoli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Caracciolo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Bonavita

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Di Costanzo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Quattrone

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

Acta Neurologica Scandinavica

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

54-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

The clinical correlates of high-titer IgG anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Antibodies to ganglioside GM1 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Diagnostic value of GM 1 antibodies in motor neuron disorders and neuropathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

Glial cells and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01240.X

7 January 2021

10.1034/J.1600-0404.2002.01240.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067330%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference